{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:48:15Z","timestamp":1792856895062,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011051","name":"Council on grants of the President of the Russian Federation","doi-asserted-by":"publisher","award":["MK-222.2021.1.3"],"award-info":[{"award-number":["MK-222.2021.1.3"]}],"id":[{"id":"10.13039\/501100011051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bioorg.2022.105925","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T01:50:12Z","timestamp":1654307412000},"page":"105925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells"],"prefix":"10.1016","volume":"127","author":[{"given":"Alexander S.","family":"Tikhomirov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir B.","family":"Tsvetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia L.","family":"Volodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria A.","family":"Litvinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria V.","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov G.","family":"Dezhenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry N.","family":"Kaluzhny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan D.","family":"Treshalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Shtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.105925_b0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bioorg.2022.105925_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199700544-00003","article-title":"Anthracyclines in the Treatment of Cancer","volume":"54","author":"Hortob\u00e1gyi","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2022.105925_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/med.21364","article-title":"Mitoxantrone, More than just another topoisomerase II poison","volume":"36","author":"Evison","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2022.105925_b0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/17474086.2018.1476848","article-title":"Pixantrone: novel mode of action and clinical readouts","volume":"11","author":"Minotti","year":"2018","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.bioorg.2022.105925_b0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline Chemotherapy and Cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bioorg.2022.105925_b0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1078155219877931","article-title":"Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance","volume":"26","author":"Al-malky","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.bioorg.2022.105925_b0035","unstructured":"K. Krohn, (Ed.) Anthracycline Chemistry and Biology II. Mode of Action, Clinical Aspects and New Drugs, Topics Curr. Chem. 283 (2009) 136-138."},{"key":"10.1016\/j.bioorg.2022.105925_b0040","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.20239","article-title":"Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression","volume":"32","author":"Nobili","year":"2012","journal-title":"Med. Res. Reviews"},{"key":"10.1016\/j.bioorg.2022.105925_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2022.105925_b0050","first-page":"05599","article-title":"Structural modification and strategies for the enhanced doxorubicin drug delivery","volume":"120","author":"Khan","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nano.2009.12.006","article-title":"Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy","volume":"6","author":"Kang","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioorg.2022.105925_b0060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jm050800q","article-title":"Discovery of a Daunorubicin Analogue That Exhibits Potent Antitumor Activity and Overcomes P-gp-Mediated Drug Resistance","volume":"49","author":"Fang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0753-3322(03)00037-4","article-title":"N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells","volume":"57","author":"Gate","year":"2003","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2022.105925_b0070","first-page":"119","article-title":"Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin","volume":"26","author":"Preobrazhenskaya","year":"2006","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.bioorg.2022.105925_b0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1574892813666171206123114","article-title":"Advances in the discovery of anthraquinone-based anticancer drugs","volume":"13","author":"Tikhomirov","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bioorg.2022.105925_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104395","article-title":"Design, synthesis and antitumor evaluation of novel anthraquinone derivatives","volume":"107","author":"Lin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0085","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00044-020-02587-4","article-title":"Design, synthesis, and antitumor evaluation of novel anthraquinone derivatives","volume":"29","author":"Oliveira","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2022.105925_b0090","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00044-020-02563-y","article-title":"Inducing apoptosis through upregulation of p53: structure\u2013activity exploration of anthraquinone analogs","volume":"29","author":"Anifowose","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2022.105925_b0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.molstruc.2018.07.070","article-title":"Synthesis and electrochemical, spectral, and biological evaluation of novel 9,10-anthraquinone derivatives containing piperidine unit as potent antiproliferative agents","volume":"1175","author":"Niedzia\u0142kowski","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2022.105925_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187971","article-title":"Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein","volume":"12","author":"Min","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2022.105925_b0105","doi-asserted-by":"crossref","first-page":"15308","DOI":"10.1002\/chem.201502154","article-title":"Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells","volume":"21","author":"Zeng","year":"2015","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2022.105925_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2020.10.031","article-title":"Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-target anticancer agents","volume":"14","author":"Ali","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0115","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1016\/j.arabjc.2015.06.017","article-title":"Synthesis and biological evaluation of anthra[1,9-cd]pyrazol-6(2H)-one scaffold derivatives as potential anticancer agents","volume":"12","author":"Chen","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carres.2018.02.012","article-title":"Synthesis of novel sugar or azasugar modified anthra[1,2-d]imidazole-6,11-dione derivatives and biological evaluation","volume":"460","author":"Wang","year":"2018","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2022.105925_b0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmech.2016.01.050","article-title":"Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties","volume":"112","author":"Shchekotikhin","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2018.12.068","article-title":"New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties","volume":"165","author":"Volodina","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112294","article-title":"Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties","volume":"199","author":"Tikhomirov","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2018.02.027","article-title":"New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship","volume":"148","author":"Tikhomirov","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0145","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/acs.jmedchem.5b00859","article-title":"Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD + \/NADH Ratio and SIRT1","volume":"58","author":"Tikhomirov","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biochi.2020.12.024","article-title":"Heteroarene-fused anthraquinone derivatives as potential modulators for human aurora kinase B","volume":"182","author":"Singh","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2022.105925_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11030420","article-title":"Engagement with tNOX (ENOX2) to inhibit SIRT1 and activate p53-dependent and -independent apoptotic pathways by novel 4,11-diaminoanthra[2,3-b]furan- 5,10-diones in hepatocellular carcinoma cells","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2022.105925_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2018.09.054","article-title":"Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties","volume":"159","author":"Tikhomirov","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187971","article-title":"Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein","volume":"12","author":"Min","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2022.105925_b0170","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1021\/bi9614489","article-title":"Circumvention of P-gp MDR as a function of anthracycline lipophilicity and charge","volume":"36","author":"Lampidis","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2022.105925_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113521","article-title":"Thiophene-2-Carboxamide Derivatives of Anthraquinone: A New Potent Antitumor Chemotype","volume":"221","author":"Volodina","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejmech.2017.01.020","article-title":"Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity","volume":"127","author":"Bisi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","article-title":"A review on anticancer potential of bioactive heterocycle quinoline","volume":"97","author":"Afzal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131418","article-title":"A facile access to 2-substituted naphtho[2,3-g]quinoline-3-carboxylic acid esters via intramolecular cyclization and PyBOP-promoted functionalization","volume":"76","author":"Litvinova","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2022.105925_b0195","first-page":"2756","article-title":"Recent Advances in the Synthesis of Coumarin Derivatives via Knoevenagel Condensation: A Review, Synth","volume":"44","author":"Vekariya","year":"2014","journal-title":"Commun. Rev."},{"issue":"5393","key":"10.1016\/j.bioorg.2022.105925_b0200","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"Bunz","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2022.105925_b0205","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1134\/S0006297906110058","article-title":"Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin","volume":"71","author":"Kalinina","year":"2006","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bioorg.2022.105925_b0210","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1073\/pnas.94.24.12908","article-title":"P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity","volume":"94","author":"Mechetner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2022.105925_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2017.03.003","article-title":"LogP, a yesterday's value?","volume":"50","author":"Vraka","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2022.105925_b0220","doi-asserted-by":"crossref","unstructured":"K. Nosol, K. Romane, R.N. Irobalieva, A. Alam, J. Kowal, N. Fujita, K.P. Locher, Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1, Proc. Natl. Acad. Sci. 117 (42) (2020) 26245\u201326253, www.pnas.org\/cgi\/doi\/10.1073\/pnas.2010264117.","DOI":"10.1073\/pnas.2010264117"},{"key":"10.1016\/j.bioorg.2022.105925_b0225","doi-asserted-by":"crossref","first-page":"16856","DOI":"10.1038\/s41598-021-96226-6","article-title":"Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp","volume":"11","author":"Laiolo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2022.105925_b0230","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jps.2600670532","article-title":"Analysis of binding of daunorubicin and doxorubicin to DNA using computerized curve-fitting procedures","volume":"67","author":"Byrn","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2022.105925_b0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11094-019-01923-2","article-title":"Antitumor activity and toxicity of olivamide dosage form, a new semi-synthetic olivomycin derivative","volume":"52","author":"Treshchalin","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2022.105925_b0240","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/acs.joc.8b00019","article-title":"Barriers to rotation in ortho-substituted tertiary aromatic amides: effect of chloro-Substitution on resonance and distortion","volume":"83","author":"Bisz","year":"2018","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/ph13120469","article-title":"N-(Hydroxyalkyl) derivatives of tris(1H-indol-3-yl)methylium salts as promising antibacterial agents: synthesis and biological evaluation","volume":"13","author":"Lavrenov","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2022.105925_b0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM, a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2022.105925_b0255","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G.A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A.V. Marenich, J. Bloino, B.G. Janesko, R. Gomperts, B. Mennucci, H.P. Hratchian, J.V. Ortiz, A.F. Izmaylov, J.L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V.G .Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J.A., Jr. Montgomery, J.E. Peralta, F. Ogliaro, M.J. Bearpark, J.J. Heyd, E.N. Brothers, K.N. Kudin, V.N. Staroverov, T.A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A.P. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J.W. Ochterski, R.L. Martin, K. Morokuma, O. Farkas, J.B. Foresman, D.J. Fox, Gaussian 16, Revision C.01, Gaussian, Inc., Wallingford CT, 2016."},{"key":"10.1016\/j.bioorg.2022.105925_b0260","doi-asserted-by":"crossref","unstructured":"Y.A. Arnautova, A. Jagielska, H.A. Scheraga, A new force field (ECEPP-05) for peptides, proteins, and organic molecules. J. Phys. Chem. B 110 (2006) 5025\u20135044, 10.1021\/jp054994x.","DOI":"10.1021\/jp054994x"},{"key":"10.1016\/j.bioorg.2022.105925_b0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2022.105925_b0270","unstructured":"Council of Europe European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. Strasbourg: 1986. [Accessed August 28, 2018]."},{"key":"10.1016\/j.bioorg.2022.105925_b0275","unstructured":"Directive 2010\/63\/EU on the protection of animals used for scientific purposes EN. Official Journal of the European Union, L 276\/33 - 276\/79 (20.10.2010)."},{"key":"10.1016\/j.bioorg.2022.105925_b0280","unstructured":"National state standard GOST P 53434-2009 the Russian Federation standard \u201cThe principles of Good Laboratory Practice\u201d (approved and put into effect by the Order of the Federal Agency for Technical Regulation and Metrology of December 2, 2009), No 544."},{"key":"10.1016\/j.bioorg.2022.105925_b0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10637-009-9329-2","article-title":"Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts","volume":"29","author":"Balandin","year":"2011","journal-title":"Invest. New Drugs."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:34:59Z","timestamp":1758616499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822003303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":57,"alternative-id":["S0045206822003303"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105925","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105925"}}